Butterfly Network, Inc. BFLY shares rallied 8.9% in the last trading session to close at $5.29. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 23% gain over the past four weeks.
Butterfly Network scored a strong price increase on investors’ optimism surrounding the company’s impending first quarter 2026 financial results, which is slated to release on April 30. Per the Zacks Consensus Estimate, the company’s revenues are expected to increase 22.5% year over year. Loss per share is pegged at 4 cents for the first quarter, indicating 33.3% year over year improvement.
This company is expected to post quarterly loss of $0.04 per share in its upcoming report, which represents a year-over-year change of +33.3%. Revenues are expected to be $26 million, up 22.5% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Butterfly Network, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on BFLY going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Butterfly Network belongs to the Zacks Medical Info Systems industry. Another stock from the same industry, Clover Health Investments, Corp. CLOV, closed the last trading session 0.5% higher at $2.16. Over the past month, CLOV has returned 14.4%.
Clover Health Investments' consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.07. Compared to the company's year-ago EPS, this represents a change of +40%. Clover Health Investments currently boasts a Zacks Rank of #3 (Hold).
#1 Semiconductor Stock to Buy (Not NVDA)
The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow.
One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be.
See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Butterfly Network, Inc. (BFLY): Free Stock Analysis Report
Clover Health Investments, Corp. (CLOV): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).